Ask the Experts

Ask the Experts

• Could Roche’s malaria test help address the national blood shortage?

  Strategies for ending the national blood shortage may include expanding the donor pool, rationing, and diagnostic tests.  Continue Reading

• Understanding the widespread impacts of pharmacy deserts

  Pharmacy deserts, perpetuated by multiple factors, have significant implications for patient care and public health.  Continue Reading

• Effectively incorporating AI into drug research, development

  A recent report from Accenture analyzes the value and impact AI can have on drug research and development.  Continue Reading

• Accurately diagnosing T1D, identifying biomarkers

  The ACCESS-T1D study works to improve T1D diagnoses among at-risk groups and identify biomarkers for more straightforward disease diagnosis.  Continue Reading

• Are compounded “DIY” peptides the answer to the GLP-1 shortage?

  The short answer is no, according to Lydia Alexander, MD, president of the Obesity Medicine Association.  Continue Reading

• Defining vaccine hesitancy, understanding how to address it

  Hilary Hatch, PhD, explores the different aspects of vaccine hesitancy and offers solutions for addressing ongoing issues.  Continue Reading

• Understanding gene therapy coverage for sickle cell disease

  Precision AQ executives discuss the recently approved gene therapies for SCD and their implications for payers and providers.  Continue Reading

• Addressing challenges in nucleotide therapeutic delivery

  Walter Strapps, PhD, Chief Scientific Officer at Liberate Bio, discusses ongoing challenges with nucleotide therapeutic delivery and how Liberate is addressing them.  Continue Reading

• Omnicell launches XT Amplify, amending pharmacy care delivery model

  The program offers several features that address ongoing challenges the company’s clients have identified in the current pharmacy care delivery model.  Continue Reading

• Exploring strategies to mitigate physician burnout

  Gail Gazelle, MD, discusses factors contributing to physician burnout, mental health stigma across the field, and strategies for addressing burnout.  Continue Reading

• Addressing muscle loss associated with GLP-1 medication use

  Scholar Rock is running a proof-of-concept study to mitigate muscle loss and enhance muscle mass in patients using GLP-1 drugs for weight management.  Continue Reading

• Comparing inflammatory bowel disease treatment options

  Marla Dubinsky, MD, compares risankizumab and ustekinumab as second-line treatments for inflammatory bowel disease.  Continue Reading

• Unraveling confusing AI regulations, their impact on life sciences

  Leaders from the Pistoia Alliance revealed that many life sciences professionals do not understand AI regulations globally, which may be hindering research.  Continue Reading

• Leveraging antibody profiling for advanced healthcare insights

  Like other omics data, antibody profiling can provide valuable healthcare insights, guiding treatment plans, drug discovery and development, and ongoing disease research.  Continue Reading

• Manufacturing complex pharmaceutical products with new technologies

  As pharmaceutical products become increasingly complex, companies can leverage new technologies in their manufacturing process to improve efficacy.  Continue Reading

• Developing Quality Assurance Standards for Biologics, Biosimilars

  Despite long-standing standards for small-molecule drugs, quality assurance guidelines for biologics and biosimilars are less robust and comprehensive.  Continue Reading

• Automating Blood Glucose Monitoring Through New Technology

  A new automated blood glucose monitor cuts down on the manual steps many people with diabetes take to check and manage their sugar daily.  Continue Reading

• What Is the Role of the Accelerating Medicines Partnership?

  The accelerating medicines partnerships are multifaceted, including collaborative healthcare research efforts at the cross-section of academia, patient care, and industry.  Continue Reading

• Is Male Birth Control the Answer to the Unplanned Pregnancy Epidemic?

  Considering half of all global pregnancies are unplanned, researchers are continuously exploring contraceptive options, including hormonal and non-hormonal male birth control.  Continue Reading

• Digitizing the Biopharmaceutical Supply Chain Improves Resilience

  Deloitte researchers evaluate the importance of digitizing the biopharmaceutical supply chain in establishing the industry’s future.  Continue Reading

• Exploring Gene and Cell Therapy Integration in Pharmacies

  Integrating gene and cell therapy in pharmacies ensures accessibility, personalized care, and effective management, enhancing patient outcomes.  Continue Reading

• Overlapping Genomic and Clinical Data Through Real-World Data Insights

  Flatiron Health collaborates with Caris Life Sciences on real-world data offering that combines genomic data with clinical insights.  Continue Reading

• Exploring and Managing GLP-1 Receptor Agonists in Weight Loss

  As GLP-1 drugs like semaglutide become increasingly popular for weight loss, providers must optimize the tools and strategies they use to manage the medications.  Continue Reading

• How the Medical Education System Contributes to Physician Burnout

  PharmaNewsIntelligence sits down with Arti Masturzo to discuss multiple components of the medical education system and how these factors contribute to burnout.  Continue Reading

• Understanding the Value of Mergers and Acquisitions in Life Sciences

  LifeSciencesIntelligence explores the primary goals of mergers and acquisitions in the life sciences industry with insight from three experts.  Continue Reading

• Evaluating the Oncology Landscape: Diagnosis, Treatment, Predictions

  As the oncology landscape evolves, evaluating trends and advancements in diagnosis and treatment may inform predictions for the coming year.  Continue Reading

• Exploring the Benefits of Digital Pathology Platforms and Sharing

  LifeSciencesIntelligence explores the implications of digital pathology integration and the benefits of data sharing in pathology.  Continue Reading

• Exploring Data Analytics in Pharmaceutical Marketing

  PharmaNewsIntelligence explores the role of data analytics in pharmaceutical marketing.  Continue Reading

• Exploring Next Year’s Medical Affairs Outlook

  LifeSciencesIntelligence explores trends in medical affairs in 2023 and upcoming 2024 predictions with Deepak Patil.  Continue Reading

• Predicting Next Year’s Life Sciences Outlook: Med Devices, Biopharma

  Deloitte’s 2024 Life Sciences Outlooks predicts medical device and biopharma trends, focusing on digital transformation, GenAI, and adopting digital health tools.  Continue Reading

• Optimizing Cancer Care Pathways Through Precision Medicine, RWD

  Real-world data and precision medicine can optimize cancer care for patients by understanding and combating complications while speeding up effective treatment options.  Continue Reading

• Analyzing Data in the Medical Device Marketing Landscape

  Understanding how to analyze and leverage data for medical device marketing is critical to product launch success.  Continue Reading

• Ensuring Equal Clinical Trial Access Across Vulnerable Communities

  CVS Health focuses on clinical trial diversity and inclusion by engaging vulnerable communities.  Continue Reading

• Exploring Pharmacy Benefit Manager Reforms: Transparency

  PharmaNewsIntelligence explores the current PBM landscape and how transparency reform differs from current industry standards.  Continue Reading

• How to Effectively Integrate AI into Clinical Trials

  PharmaNewsIntelligence interviews Tobias Guennel on effective AI integration, safety, and validation in clinical trials.  Continue Reading

• Analyzing 2023 Technology Trends in the Life Sciences Industry

  Accenture’s report highlighted technology trends in the biopharma industry throughout 2023.  Continue Reading

• Evaluating the Breast Cancer Therapeutics Market

  An analyst at Citeline provided PharmaNewsIntelligence with insights into current trends, gaps, and predictions in the breast cancer therapeutics market.  Continue Reading

• Essential Factors for Launching New Medical Imaging Technology

  As Exo launches Iris, its newest medical imaging device, Sandeep Akkaraju provided insights into the factors contributing to a medical technology launch.  Continue Reading

• The Importance of Accurately Measuring the Value of New Medications

  NPLB noted that including factors, such as diminishing returns and dynamic pricing, helps assess medication value better than traditional CEA.  Continue Reading

• How Can Pharmaceutical Companies Meet Drug Launch Expectations

  Deloitte analysts assess market data to understand why many pharmaceutical companies miss expectations during drug launches.  Continue Reading

• What Is Comprehensive Reproductive Psychiatry and Mental Healthcare?

  Sarah Oreck, MD, CEO and co-founder of Mavida Health, provides insight into the emerging field of reproductive psychiatry.  Continue Reading

• Evaluating Tenets of Comprehensive Maternal Mental Healthcare

  These components may improve maternal mental health and outcomes across the United States.  Continue Reading

• Why This Dual Chamber Auto-Injector Won Three Design Awards

  The auto-injector is a dual-chamber, automatic, reusable device for pediatric patients with growth hormone deficiency.  Continue Reading

• Vaccinations Needed to Prevent COVID-19 ED Visits, Hospitalization

  Researchers quantified the number needed to vaccinate to eliminate one COVID-19 ED visit or hospitalization.  Continue Reading

• GSK Launches New Platform for Tracking Adult Vaccination Rates

  GSK recently launched a new platform for adult vaccine tracking as part of its COiMMUNITY Initiative for improving adult vaccination.  Continue Reading

• Restoring Hearing Through Cell Reprogramming and Regeneration

  Harvard scientists have developed a new hearing loss treatment that restores hearing via cell reprogramming and regeneration.  Continue Reading

• Understanding HIV Incidence Trends and Prevention Strategies

  A recent report by the CDC analyzed HIV incidence trends in 2021, highlighting the beneficial impact of prevention strategies; however, there are inequities in improvement.  Continue Reading

• How Inflation, Competition, Biosimilars Affect Prescription Drug Costs

  Inflation drives up prescription drug prices, but biosimilars and competition can reduce costs.  Continue Reading

• Examining Challenges and the Potential of Integrating AI in Healthcare

  Exploring AI integration in healthcare is crucial for improving outcomes and revolutionizing the medical industry.  Continue Reading

• Addressing Clinical Trial Challenges and High Drug Development Costs

  Clinical researchers seek new tools and assets to address clinical trial challenges linked to high drug development costs.  Continue Reading

• FNIH Enhances Rare Disease Research by Adding 8 Diseases to BGTC

  A recent announcement by the FNIH revealed it would add eight rare diseases to its BGTC to accelerate and enhance rare disease research, providing a template for future efforts.  Continue Reading

• Male Birth Control Gel Provides New Contraceptive Options for Men

  Collaborative research efforts have brought researchers close to a new male contraceptive option, a hormonal male birth control gel, adding to the short list of options for men.  Continue Reading

• Using Digital Health Solutions to Address Rural Healthcare Disparities

  Limited access to specialty healthcare results in healthcare disparities for rural Americans, but the emergence of digital health solutions offers a promising strategy to improve healthcare access.  Continue Reading

• Detecting and Monitoring Health Conditions and Risks with Ocular Exams

  Despite being considered a separate component of health by insurers, ocular exams can detect, monitor, and provide insight into health conditions and risks.  Continue Reading

• Oral Ketamine Treatment: An Alternative to Ketamine Infusions

  Despite proven efficacy in managing treatment-resistant depression, ketamine therapy can have multiple limitations; however, oral ketamine treatment may provide a more accessible alternative.  Continue Reading

• Developmental Outcomes Linked to COVID-19 Exposure During Pregnancy

  Clinicians have collected data and analyzed the impact of COVID-19 exposure during pregnancy; new insight reveals the developmental outcomes associated with in utero exposure.  Continue Reading

• Advancing Health Equity with Clinical Trial Diversity: Key Strategies

  Although research has consistently displayed a lack of participant diversity in clinical trials, improving clinical trial diversity is a key strategy for advancing health equity.  Continue Reading

• Improving Transplant Equity by Bioengineering Organs for Transplants

  Could bioengineering organs for human organ transplants improve transplant equity and address the ongoing organ shortage?  Continue Reading

• Drug Shortages: A Growing Concern for the Healthcare Industry Worldwide

  Drug shortages pose a significant challenge for healthcare providers worldwide, leaving patients without essential medications and healthcare providers struggling to find alternative treatment options.  Continue Reading

• Understanding the FDA Medical Device Cybersecurity Protocols

  As the FDA incorporates its new medical device cybersecurity protocols and plans for strict enforcement in October 2023, it is critical to understand guidance components and their legal implications.  Continue Reading

• Have Stanford Researchers Developed the Blood Test Theranos Couldn’t?

  Stanford researchers have developed a multi-omics microsampling blood test, coming closer to achieving what Theranos fraudulently claimed to do but couldn’t.  Continue Reading

• Exploring Applications of Augmented and Mixed Reality in Healthcare

  Cutting-edge augmented and mixed reality (AR/MR) is transforming the healthcare industry with innovative applications that unprecedentedly improve patient outcomes.  Continue Reading

• A New Era in Medicine: The Therapeutic Promise of HMO-Based Medications

  Human milk oligosaccharides (HMOs) are complex carbohydrates in human breast milk that have numerous health benefits, spurring research efforts to develop a promising new class of drugs.  Continue Reading

• Defeating the Stigma: Normalizing At-Home Testing and Treatment for STIs

  At-home STI testing companies are normalizing testing and treatment by offering convenient, affordable, and private testing for STIs without visiting a doctor's office or clinic and providing discreet online consultations and treatment options.  Continue Reading

• Understanding Vaginal Microbiomes with Vagina-on-a-Chip Models

  Using organ-on-a-chip models, researchers at Harvard University have developed a vagina-on-a-chip to model vaginal microbiome host interactions.  Continue Reading

• Minimizing Prescription Abandonment and Nonadherence with Digital Tools

  A new approach by DrFirst uses digital tools to minimize prescription abandonment and nonadherence rates in the US.  Continue Reading

• Nectin Therapeutics Collaborates with Merck on Cancer Treatment

  Nectin Therapeutics and Merck have collaborated on a new cancer treatment that combines Keytruda with a novel anti-PVR antibody treatment.  Continue Reading

• Using Genomic Profiling in Oncology Advances Precision Medicine

  In the era of precision medicine, genomic profiling may be a critical tool in oncology to assess a patient’s response to treatment or advance oncological research.  Continue Reading

• Analyzing Returns on Investment from Pharmaceutical Innovation

  It is increasingly critical for pharmaceutical innovation leaders to analyze returns on investments while managing their business practices.  Continue Reading

• Finding Solutions for Drug Shortages: Short and Long-Term Management

  The impact of drug shortages on patients, providers, and healthcare spending has left industry leaders looking for short- and long-term management solutions.  Continue Reading

• Understanding Multiple Sclerosis and the Role of Specialty Care

  Specialty care teams have a crucial role in managing multiple sclerosis by imparting knowledge to patients, administering follow-up care, and simplifying medication information.  Continue Reading

• Analyzing 2023 Drug List Price Increases by Pharmaceutical Companies

  To kick off the new year, an Ohio-based nonprofit analyzed drug list price increases by pharmaceutical companies in January 2023 using proprietary data.  Continue Reading

• The Importance of Delaying the Onset of Type 1 Diabetes with New Treatment

  For those with type 1 diabetes, a new monoclonal antibody treatment delays the clinical diagnosis of stage 3 diabetes for 2 years, pausing disease burdens and improving the quality of life.  Continue Reading

• Identifying and Preventing Prescriber Identity Theft in the Digital Era

  Identifying and preventing prescriber identity theft in the digital era is a complicated but critical process for minimizing the impacts on patients, providers, and the healthcare system.  Continue Reading

• Standardizing Measurements of Sleep, Discrepancies Among Digital Tools

  Despite the importance of sleep and the multitude of digital tools intended to measure its quality, there are many discrepancies among sleep measurements, indicating a need for more standardization.  Continue Reading

• Understanding the Impacts of COVID-Positive Organ Transplants

  Although the early stages of the COVID-19 pandemic significantly reduced the number of solid organ transplants, data from the later days of the pandemic has helped providers better understand the impacts of COVID-positive organ transplants.  Continue Reading

• Drug Repurposing May Benefit Rare Disease, Considerations, and Caveats

  Drug repurposing may benefit the roughly 7,000 existing rare diseases for which there are limited research and treatment options; however, researchers and advocates must understand the considerations and caveats created by the current pharmaceutical...  Continue Reading

• How Naloxone Co-Prescribing Laws Can Facilitate Opioid Education

  Legislation regarding naloxone and opioid co-prescribing laws may facilitate opioid education by allowing healthcare professionals to discuss the risk of opioid use and emergency overdose care.  Continue Reading

• 3D Bioprinting Eye Tissue to Advance Degenerative Eye Disease Research

  In an article published in Nature, researchers 3D bio-printed eye tissue, specifically the outer retina barrier, to advance research on degenerative eye diseases.  Continue Reading

• Understanding Unique Challenges in Pediatric Organ Transplants

  In addition to the general complexities of organ transplants, pediatric organ transplants are associated with unique challenges, ranging from organ matching to post-transplant care.  Continue Reading

• Cancer Diagnosis Lags Have Continued 2 Years into the Pandemic

  A study on prostate, breast, colorectal, pancreatic, cervical, gastric, and esophageal cancer found that diagnosis rates have lagged behind pre-pandemic rates, even two years into the pandemic.  Continue Reading

• RSV, How Pharmacists Can Help Patients Prevent and Manage Infections

  To promote awareness during the national surge of RSV and other respiratory infections, pharmacists are in a prime position to help their patients prevent and manage RSV infections.  Continue Reading

• Advancing Maternal Health Equity Research: Current Gaps and Trends

  Among all developed countries, the United States has some of the highest maternal mortality and morbidity; however, advancing maternal health equity through research focused on current gaps and trends may improve outcomes.  Continue Reading

• Mitigating Colorectal Cancer Treatment Risks Through ctDNA Testing

  The treatments for colorectal cancer are associated with many risks, including infertility, which may be mitigated by incorporating ctDNA testing into medical decisions.  Continue Reading

• How Virtual Reality Could Reform Surgical Training

  The use of virtual reality technology in surgical training could prepare doctors globally for complex situations, decrease surgical complications, and improve patient outcomes.  Continue Reading

• Deep Learning Technology Improves Diagnostic Pathway for Brain Tumors

  Combining nanoparticles, liquid biopsy, and deep learning technology may improve the diagnostic pathway for brain tumors, which currently consists of tissue biopsy and imaging.  Continue Reading

• Understanding the Rise of the Tripledemic, Vaccination Minimizes Risk

  As RSV, influenza, and COVID rates rise, contributing to the tripledemic, vaccination and educational efforts may help minimize disease spread, reduce the risk of severe illness, and alleviate the burden on the healthcare system.  Continue Reading

• Migraine Treatment Gap Is Rooted in a Lack of Awareness

  With approximately 10% of the world’s population experiencing migraines, the migraine treatment gap, rooted in a lack of awareness and understanding, significantly impacts patient care and comfort.  Continue Reading

• Improving Clinical Trial Diversity Through Community and Pharmaceutical Relationships

  Persistent gaps in clinical trial diversity may be improved by building relationships between community sites and pharmaceutical companies through global platforms.  Continue Reading

• Anticipating the 2023 Biosimilar Boom

  As the comfort and familiarity of biosimilars have grown, many industry leaders anticipate a 2023 biosimilar boom, predicting that by 2028 the market will be worth $103.94 billion.  Continue Reading

• New Commercially Available PCR Test Detects 3 Brain-Eating Amoebas in 3 Hours

  A new commercially available PCR test can detect three common brain-eating amoebas in three hours: Naegleria fowleri, Balamuthia mandrilaris, and Acanthamoeba spp.  Continue Reading

• How Can Providers Help Patients Navigate Increased Drug Costs?

  With the rising trends of prescription drug costs driven by research and development, launch prices, and market exclusivity, providers may be able to address accessibility issues by helping patients navigate these increased costs.  Continue Reading

• Exploring Psychedelics to Treat Mental Health Issues

  In recent years, many healthcare professionals have highlighted and explored the benefits of psychedelics, such as ketamine, to treat mental health issues including treatment-resistant depression.  Continue Reading

• Digitizing the Diagnostic Pathway for Dementia

  Digitizing portions of the diagnostic pathway for dementia may help reduce diagnostic barriers and alleviate burdens on providers.  Continue Reading

• Reimagining the Global Pharmaceutical Supply Chain

  Reimagining the global pharmaceutical supply chain to address current issues is essential for ensuring that patients and providers have access to the care and supplies they need.  Continue Reading

• A Reversible Alternative to Vasectomies on the Horizon for 2024

  The discovery of a long-acting, nonhormonal, and reversible alternative to a vasectomy could alleviate the burden of pregnancy prevention, leading to equal contraceptive options across genders.  Continue Reading

• HHS Grants $15 Million to Certified Behavioral Health Clinics

  On October 18, 2022, the HHS announced that it would award $15 million in grants across 15 states for certified behavioral health clinics.  Continue Reading

• Understanding the Implications, Benefits, Challenges of 3D Pathology

  As 3D pathology continues to grow, understanding the benefits and drawbacks of the technology is increasingly important in deciding which diagnostic route to take.  Continue Reading

• How to Integrate Remote Patient Monitoring Across Cancer Care Settings

  Remote patient monitoring can be a critical tool for cancer care settings; understanding how to integrate these tools for effective care is necessary to improve patient outcomes.  Continue Reading

• Using AI to Predict a Viable Pregnancy During IVF

  Understanding how to use AI to predict a viable pregnancy may be valuable knowledge for embryologists and other clinicians who perform IVF.  Continue Reading